Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38375
CAS Number:
81938-43-4
Zofénopril calcique
Purity:
≥ 97 % (HPLC)
Synonym(s):
Sel de calcium de (4S)-1-[(2S)-3-(benzoylthio)-2-méthyl-1-oxopropyl]-4-(phénylthio)-L-proline
Documents
$334.10 /25 mg
Taille
Request Bulk Quote
Informations sur le produit

Zofenopril calcium is a potent angiotensin-converting enzyme (ACE) inhibitor, primarily utilized in the management of hypertension and heart failure. This compound is recognized for its ability to effectively lower blood pressure and improve cardiac function, making it a valuable asset in cardiovascular therapy. Its unique structure allows for enhanced bioavailability and prolonged action compared to other ACE inhibitors, providing patients with sustained therapeutic benefits.

In addition to its primary applications in treating cardiovascular conditions, Zofenopril calcium has shown promise in research settings, particularly in studies focused on renal protection and diabetic complications. Its ability to mitigate oxidative stress and inflammation further underscores its potential in various therapeutic areas. Researchers and healthcare professionals can leverage Zofenopril calcium's multifaceted benefits to improve patient outcomes in both clinical and experimental settings.

Numéro CAS 
81938-43-4
Formule moléculaire
C44H44CaN2O8S4
Poids moléculaire 
897.16
Point de fusion 
246 °C
Informations générales
Numéro CAS 
81938-43-4
Formule moléculaire
C44H44CaN2O8S4
Poids moléculaire 
897.16
Point de fusion 
246 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Zofenopril calcium is widely utilized in research focused on:

  • Cardiovascular Health: This compound is primarily used in the treatment of hypertension and heart failure, helping to manage blood pressure effectively and reduce the risk of cardiovascular events.
  • Pharmaceutical Development: Zofenopril calcium serves as a key ingredient in various antihypertensive medications, making it crucial for pharmaceutical companies developing new treatments for high blood pressure.
  • Clinical Research: Researchers often study its effects in clinical trials to better understand its efficacy and safety profile compared to other ACE inhibitors, providing valuable data for healthcare professionals.
  • Combination Therapies: It is frequently used in combination with other antihypertensive agents, enhancing treatment outcomes for patients with complex health conditions.
  • Patient Compliance: The formulation of Zofenopril calcium allows for once-daily dosing, which can improve patient adherence to treatment regimens, a significant advantage in chronic disease management.

Citations